Page 4 - Oxford Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oxford sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oxford Sciences Today - Breaking & Trending Today

Nucleome Therapeutics announces publication of a novel method enabling 3D genome mapping at single base pair resolution in the journal Nature

Nucleome Therapeutics announces publication of a novel method enabling 3D genome mapping at single base pair resolution in the journal Nature New method is being used by Nucleome to unlock the dark matter of the human genome for drug target discovery with exceptional precision Oxford, UK, 10 June 2021 – Nucleome Therapeutics (“Nucleome”), a biotechnology company decoding the dark matter of the human genome to uncover novel ways to treat disease, today announces the publication of a novel 3D geno ....

United Kingdom , James Davies , Jim Hughes , Danuta Jeziorska , Oxford Sciences Innovation , University Of Oxford , Academic Co , Consilium Strategic Communications , Nucleome Therapeutics , Micro Capture C , Prof James Davies , Academic Co Founder , Associated Professor , Chief Executive Officer , Prof Jim Hughes , Gene Regulation , Oxford Sciences , Genome Mapping , University Of Oxford , Genome Analysis , Dark Matter , Genome Structure , Base Pair , Novel Method , Genome Maps , ஒன்றுபட்டது கிஂக்டம் ,

Scientists make DNA breakthrough which could identify why some people are more affected by Covid-19

Date Time
Scientists make DNA breakthrough which could identify why some people are more affected by Covid-19
Scientists from the MRC Weatherall Institute of Molecular Medicine at Oxford University have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.
This breakthrough will improve understanding of how differences in DNA sequences can lead to increased risks of developing many different diseases.
The method, which is around 1000 times more accurate than existing techniques, enables scientists to measure the contacts between different pieces of DNA, which are a million base pairs apart to the nearest base pair. This is the equivalent of being able to measure contacts in the DNA fibre that are 1km apart to the nearest millimetre. ....

James Davies , Radcliffe Department Of Medicine , Oxford Sciences Innovation , University Of Oxford , Molecular Medicine , Oxford University , Professor James Davies , Radcliffe Department , Nucleome Therapeutics , Oxford Sciences , Rheumatoid Arthritis , Multiple Sclerosis , Clinical Trials , Cell Nucleus , Human Health , ஜேம்ஸ் டேவிஸ் , ராட்க்ளிஃப் துறை ஆஃப் மருந்து , ஆக்ஸ்ஃபர்ட் அறிவியல் கண்டுபிடிப்பு , பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட் , மூலக்கூறு மருந்து , ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் , ராட்க்ளிஃப் துறை , ஆக்ஸ்ஃபர்ட் அறிவியல் ,

How one of the UK's brightest startups lost its rights to the Oxford vaccine

How one of the UK’s brightest startups lost its rights to the Oxford vaccine
Vaccitech is about to float for $700m in New York, but its vaccine heroics are a mere footnote in its prospectus for potential investors
18 April 2021 • 12:00pm
At Oxford University, a long history of scientific triumph has often not been matched by commercial success. Its failure to exploit the discovery of antibiotics haunts the dreaming spires, according to Robin Wright, the chairman of the Covid vaccine developer Vaccitech.
“A hundred years ago, they were the developers of Alexander Fleming’s big idea,” he says. “They produced the penicillin but they didn’t patent it properly, so they never made any money off it. ....

New York , United States , United Kingdom , City Of , Quinton Fivelman , Sarah Gilbert , Alexander Fleming , John Bell , Robin Wright , Adrian Hill , Oxford University Innovation , Oxford Sciences Innovation , University Of Oxford , Jenner Institute , Oxford Jenner Institute , Oxford University , Middle Eastern Respiratory Syndrome , Sir John Bell , Oxford Sciences , Sir John , Wall Street Journal , Bill Enright , Sciences Innovation , Professor Adrian Hill , Wall Street , புதியது யார்க் ,

A Virtual Events Startup With $670 Million And The 19 Other Highest-Funded Forbes Under 30 Europe Honorees

11:50pm EDT|
A Virtual Events Startup With $670 Million And The 19 Other Highest-Funded Forbes Under 30 Europe Honorees
Illustration by Alexander Wells for Forbes
Share to Facebook
These companies have all raised over $10 million in funding.
While 2020 brought public life to a halt, venture capitalists cut checks at an unmatched volume. The 20 companies on 2021 30 Under 30 Europe Big Money list captured some the largest investments as all raised upwards of $10 million. These companies range from finance to science and all have an Under 30 honoree at the helm.
The list’s highest funded startup Hopin has attracted $670 million from investors to enliven virtual events, surpassing other Under 30 Europe 2021 companies by the hundreds of millions. The company is founded by 28-year-old London-based engineer Johnny Boufarhat and has attracted top tier investors like Andreessen Horowitz, General Catalyst and IVP, whose checks have given the two-year-old company ....

New York , United States , Eteläuomen Läi , Nordrhein Westfalen , City Of , United Kingdom , Andrea Castiglione , Steve Wozniak , Yolanda Schmidtke , Johnny Boufarhat , Andreessen Horowitz , Jesaja Brinkmann , Charlotte Casebourne , Oxford Sciences Innovation , University Medical Center Hamburg , Big Money , General Catalyst , Finland Based Swappie , Telia Ventures , Epidarex Capital , Taiho Ventures , Oxford Sciences , University Medical Center Hamburg Eppendorf , Cara Care , Asana Labs , புதியது யார்க் ,

AstraZeneca vaccine scientists set for £22m payday in New York float

AstraZeneca vaccine scientists set for £22m payday in New York float
Rupert Neate Wealth correspondent
Prof Sarah Gilbert, the Oxford University scientist who lead the team that created the Oxford/AstraZeneca coronavirus vaccine, is set for a payday of more than £20m as the vaccine technology firm she co-founded prepares to float on the New York stock exchange.
Popular Searches
Gilbert, who became a household name as a result of her work creating Oxford’s Covid-19 vaccine, owns just over 5% of Vaccitech, a Oxford University spin-out company that owns the biotechnology behind the AstraZeneca coronavirus vaccine and others for Mers, hepatitis B, the virus that causes shingles, and a range of cancers. ....

New York , United States , United Kingdom , Oxford Astrazeneca , Sarah Gilbert , Oxford Astrazeneca Covid , Oxford Covid , Adrian Hill , Oxford Sciences Innovation , Sequoia Capital , Oxford University , Companies House , Prof Sarah Gilbert , Prof Adrian Hill , Financial Times , Oxford Sciences , Huawei Technologies , Astrazeneca Covid , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , சாரா கில்பர்ட் , ஆக்ஸ்ஃபர்ட் அறிவியல் கண்டுபிடிப்பு , சீக்வோயா மூலதனம் , ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் , நிறுவனங்கள் வீடு ,